Haemochromatosis UK Announces New Chief Executive

Earlier this year Haemochromatosis UK (HUK) announced plans to expand the senior management team at the charity by appointing a new Chief Executive and creating an Operations Executive role to be taken up by David Head, the existing Chief Executive.  The trustees are delighted to confirm that this has been progressed exactly as planned and the selection process completed.

Neil McClements, New Chief Executive at Haemochromatosis UK

Corrina Towers, Chair at HUK, said “The process of recruiting our new Chief Executive has been the most important decision we have had to make this year, so the recruitment process had to be very robust. We had over 30 applications which is testament to the external perception of our organisation and the opportunities we have. As a Board we are delighted with our appointment and are excited about where our new CEO can take HUK in the future.”

The HUK Board of Trustees have appointed Neil McClements as our new Chief Executive. Neil joined HUK as a trustee in the autumn of 2017 after having been diagnosed with GH in 2015. He lives in Lincolnshire with his wife and children, and has a solid business background alongside valuable third sector CEO experience in leading a charity that supports people with a lesser-known medical condition. In July, we will feature an interview with Neil to give members the chance to learn more about him and his ambitions for HUK.

Neil said “I’m excited to join HUK at such a pivotal time, building upon the tremendous success that David and the team have achieved over recent years. I look forward to meeting members over the coming weeks as we work together to make this our best year ever for HUK!”

David Head, former Chief Executive, now Operations Executive commented, “I am incredibly proud of what has been achieved by Haemochromatosis UK in the last few years. I am absolutely delighted to see this investment in the charity’s future. I look forward to working with Neil and I have no doubt that we, our members and haemochromatosis patients across the UK can only benefit from the changes to come.”


Notes

Haemochromatosis/GH is a genetic disorder causing the body to absorb excessive iron from the diet. Characterised by joint pain and disease, chronic fatigue and weakness, cognitive and psychological difficulties, sexual health issues, skin problems, abnormal liver function, diabetes, and cardiomyopathy. Iron overload can be fatal. It is usually easily treated if diagnosed early.

If you believe you have haemochromatosis or any other condition, please talk to your GP.